Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PSX vs GSK✓SelectedUSD · GSKPSX vs GSK performance historyLatest closeAs of-4.71%11/18
Stock and ETF performance explorer

PSX vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+126.8%
GSK return
+56.0%
Excess return
+70.8%
Maximum drawdown
-44.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.7%-1.3%-3.4%-4.7%
7D-5.4%-3.1%-2.2%-5.3%
30D-15.7%-0.9%-14.8%-15.7%
3M+0.6%-4.2%+4.7%+0.7%
6M+36.9%-1.6%+38.5%+36.7%
YTD+93.7%+2.6%+91.1%+90.8%
1Y+80.6%+6.2%+74.4%+77.1%
All+126.8%+56.0%+70.8%+99.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling